Samsung Galaxy Watch 6 to Revolutionize Heart Monitoring with FDA Approval.

Samsung's upcoming Galaxy Watch 6 series will feature an FDA-cleared Irregular Heart Rhythm Notification (IHRN) component, allowing users to monitor their heart rate for signs of atrial fibrillation (AFib) using the BioActive Sensor. The IHRN feature will also be available on previous Galaxy Watch editions via an update. The One UI 5 Watch update will bring personalized heart rate zones, improved safety features, and better sleep tracking. Samsung prioritizes proactive safety solutions and enables users to receive a more holistic understanding of their cardiovascular and overall health.